New patent for Rvl Pharms drug UPNEEQ

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for UPNEEQ
Annual Drug Patent Expirations for UPNEEQ

Upneeq is a drug marketed by Rvl Pharms and is included in one NDA. There are eight patents protecting this drug.

This drug has thirty-five patent family members in twenty-five countries.

The generic ingredient in UPNEEQ is oxymetazoline hydrochloride. Additional details are available on the oxymetazoline hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top